00000nam 2200000za 4500 9.855992 CaOODSP 20221107155432 cr ||||||||||| 180430s2018 onc ob f000 0 eng d 9780660264387 CaOODSP eng n-cn--- HP40-213/2018E-PDF NACI literature review on the comparative effectiveness and immunogenicity of subunit and split virus inactivated influenza vaccines in adults 65 years of age and older [electronic resource]. At head of title: Advisory committee review, National Advisory Committee on Immunization (NACI) [Ottawa] : Public Health Agency of Canada, 2018. 29 p. Issued also in French under title: Revue de la littérature du CCNI sur l’efficacité comparative et l’immunogénicité du vaccin antigrippal inactivé sous unitaire et du vaccin antigrippal inactivé à virion fragmenté chez les adultes âgés de 65 ans et plus. Cover title. "Publication date: May 2018." Prepared by: K. Young ... [et al.]. Cf. Acknowledgements. Includes bibliographical references (p. 13-14). "Subunit and split virus inactivated influenza vaccines are two commonly used types of seasonal influenza vaccines, and continue to dominate the market in Canada. Although these two formulations of influenza vaccine have been available for many decades, NACI has not previously conducted a literature review to investigate the comparative vaccine effectiveness of these different formulations. A difference in vaccine effectiveness between these formulations would be especially important for older adults (65 years of age or older), since there is evidence that older adults experience more severe illness due to influenza and have reduced vaccine effectiveness compared to younger adults. To address this gap, NACI conducted a literature review to examine the vaccine effectiveness and immunogenicity of unadjuvanted, standard dose subunit inactivated influenza vaccines compared to unadjuvanted, standard dose split virus inactivated influenza vaccines in adults 65 years of age and older"--Executive summary, p. 3. gccst Seniors gccst Immunization gccst Influenza Canada. National Advisory Committee on Immunization. Public Health Agency of Canada. Revue de la littérature du CCNI sur l’efficacité comparative et l’immunogénicité du vaccin antigrippal inactivé sous unitaire et du vaccin antigrippal inactivé à virion fragmenté chez les adultes âgés de 65 ans et plus (CaOODSP)9.855993 PDF 1.25 MB https://publications.gc.ca/collections/collection_2018/aspc-phac/HP40-213-2018-eng.pdf 180039